Taken together, we first demonstrated that I3C induces miR-34a, which then targets LDHA, a vital enzyme for aerobic glycolysis, by inhibiting the degradation of p53 by MDM2, thereby downregulating the expression of LDHA and suppressing aerobic glycolysis, leading to growth inhibition of liver cancer cells. This evidence concerns the gene TP53 and liver cancer.